Life Sciences Investment Banking
An experienced team in a vibrant sector.
Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.
Life Sciences Subsector Expertise
- Biotechnology
- Pharmaceutical Services
- Pharmaceutical Technology
- Pharmaceutical Supply Chain
- Specialty Pharmaceuticals
Senior Banking Team
Transaction History
Transaction history may include a transaction completed by a Raymond James banker while at a former firm.
Recent News
Investment Banking
|
December 12, 2024
Raymond James expands financial services investment banking practice, hires Managing Director Craig Tessimond
Read more about Raymond James expands financial services investment banking practice, hires Managing Director Craig Tessimond
Investment Banking
|
October 3, 2024
Raymond James continues growth of consumer investment banking practice, hiring Managing Director ChanChan Wang
Read more about Raymond James continues growth of consumer investment banking practice, hiring Managing Director ChanChan Wang
Public Finance
|
July 16, 2024